These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37278486)

  • 1. Divergent Total Synthesis and Characterization of Maxamycins.
    Moore MJ; Qin P; Keith DJ; Wu ZC; Jung S; Chatterjee S; Tan C; Qu S; Cai Y; Stanfield RL; Boger DL
    J Am Chem Soc; 2023 Jun; 145(23):12837-12852. PubMed ID: 37278486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Total syntheses and initial evaluation of [Ψ[C(═S)NH]Tpg⁴]vancomycin, [Ψ[C(═NH)NH]Tpg⁴]vancomycin, [Ψ[CH₂NH]Tpg⁴]vancomycin, and their (4-chlorobiphenyl)methyl derivatives: synergistic binding pocket and peripheral modifications for the glycopeptide antibiotics.
    Okano A; Nakayama A; Wu K; Lindsey EA; Schammel AW; Feng Y; Collins KC; Boger DL
    J Am Chem Soc; 2015 Mar; 137(10):3693-704. PubMed ID: 25750995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Total synthesis of [Ψ[C(═S)NH]Tpg4]vancomycin aglycon, [Ψ[C(═NH)NH]Tpg4]vancomycin aglycon, and related key compounds: reengineering vancomycin for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Xie J; Okano A; Pierce JG; James RC; Stamm S; Crane CM; Boger DL
    J Am Chem Soc; 2012 Jan; 134(2):1284-97. PubMed ID: 22188323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.
    Wu ZC; Boger DL
    Acc Chem Res; 2020 Nov; 53(11):2587-2599. PubMed ID: 33138354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Total synthesis of [Ψ[C(═NH)NH]Tpg(4)]vancomycin and its (4-chlorobiphenyl)methyl derivative: impact of peripheral modifications on vancomycin analogues redesigned for dual D-Ala-D-Ala and D-Ala-D-Lac binding.
    Okano A; Nakayama A; Schammel AW; Boger DL
    J Am Chem Soc; 2014 Oct; 136(39):13522-5. PubMed ID: 25211770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved preparative enzymatic glycosylation of vancomycin aglycon and analogues.
    Moore MJ; Qin P; Keith DJ; Boger DL
    Tetrahedron; 2023 Jan; 131():. PubMed ID: 36776940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vancomycin C-Terminus Guanidine Modifications and Further Insights into an Added Mechanism of Action Imparted by a Peripheral Structural Modification.
    Wu ZC; Cameron MD; Boger DL
    ACS Infect Dis; 2020 Aug; 6(8):2169-2180. PubMed ID: 32598127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral modifications of [Ψ[CH
    Okano A; Isley NA; Boger DL
    Proc Natl Acad Sci U S A; 2017 Jun; 114(26):E5052-E5061. PubMed ID: 28559345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-Generation Total Synthesis of Vancomycin.
    Moore MJ; Qu S; Tan C; Cai Y; Mogi Y; Jamin Keith D; Boger DL
    J Am Chem Soc; 2020 Sep; 142(37):16039-16050. PubMed ID: 32885969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycopeptide antibiotic analogs efficient against vancomycin-resistant bacteria: a patent evaluation (WO2013022763).
    Olsufyeva EN; Preobrazhenskaya MN
    Expert Opin Ther Pat; 2013 Dec; 23(12):1625-34. PubMed ID: 23972226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of vancomycin and vancomycin aglycon analogues that bear modifications in the residue 3 asparagine.
    McAtee JJ; Castle SL; Jin Q; Boger DL
    Bioorg Med Chem Lett; 2002 May; 12(9):1319-22. PubMed ID: 11965380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotyping of enterotoxigenic methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VRSA) among commensal rodents in North Sinai, Egypt.
    Eidaroos NH; Youssef AI; El-Sebae A; Enany ME; Farid DS
    J Appl Microbiol; 2022 Mar; 132(3):2331-2341. PubMed ID: 34297868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of the Staphylococcal VraTSR regulatory system on vancomycin resistance and vanA operon expression in vancomycin-resistant Staphylococcus aureus.
    Qureshi NK; Yin S; Boyle-Vavra S
    PLoS One; 2014; 9(1):e85873. PubMed ID: 24454941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New lipoglycopeptides: a comparative review of dalbavancin, oritavancin and telavancin.
    Zhanel GG; Calic D; Schweizer F; Zelenitsky S; Adam H; Lagacé-Wiens PR; Rubinstein E; Gin AS; Hoban DJ; Karlowsky JA
    Drugs; 2010 May; 70(7):859-86. PubMed ID: 20426497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamic activity of ceftobiprole compared with vancomycin versus methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-intermediate Staphylococcus aureus (VISA) and vancomycin-resistant Staphylococcus aureus (VRSA) using an in vitro model.
    Zhanel GG; Voth D; Nichol K; Karlowsky JA; Noreddin AM; Hoban DJ
    J Antimicrob Chemother; 2009 Aug; 64(2):364-9. PubMed ID: 19454524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergence of vancomycin-intermediate and -resistant Staphylococcus aureus among methicillin-resistant S. aureus isolated from clinical specimens in the northwest of Iran.
    Ghahremani M; Jazani NH; Sharifi Y
    J Glob Antimicrob Resist; 2018 Sep; 14():4-9. PubMed ID: 29454049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A redesigned vancomycin engineered for dual D-Ala-D-ala And D-Ala-D-Lac binding exhibits potent antimicrobial activity against vancomycin-resistant bacteria.
    Xie J; Pierce JG; James RC; Okano A; Boger DL
    J Am Chem Soc; 2011 Sep; 133(35):13946-9. PubMed ID: 21823662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methicillin- and Vancomycin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococci Isolated from Hospital Foods: Prevalence and Antimicrobial Resistance Patterns.
    Afshari A; Taheri S; Hashemi M; Norouzy A; Nematy M; Mohamadi S
    Curr Microbiol; 2022 Sep; 79(11):326. PubMed ID: 36125553
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cervimycin-Resistant Staphylococcus aureus Strains Display Vancomycin-Intermediate Resistant Phenotypes.
    Dietrich A; Steffens U; Gajdiss M; Boschert AL; Dröge JK; Szekat C; Sass P; Malik IT; Bornikoel J; Reinke L; Maček B; Franz-Wachtel M; Nieselt K; Harbig T; Scherlach K; Brötz-Oesterhelt H; Hertweck C; Sahl HG; Bierbaum G
    Microbiol Spectr; 2022 Oct; 10(5):e0256722. PubMed ID: 36173303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
    Tiwari HK; Sen MR
    BMC Infect Dis; 2006 Oct; 6():156. PubMed ID: 17067393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.